Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by Electrospiroon Oct 09, 2014 1:18am

241 Views

Post# 23013199

RE:RE:RE:Q1 earnings

I think that this is/was an artificially created sell off. There is no reason to panic. We have Q1 results coming soon and those I expect will be good and maybe very good, analyst 'buy' recommendation with a target of $2.80. I would definitely buy some more shares if I have more money. I havn't sold at $2.80 -$3 because Medicure will be worth more than that!

Bullboard Posts

Who, why, and what of the great "Crypto Surge"